C4 Therapeutics to Participate in Upcoming March Investor Conferences

Core Insights - C4 Therapeutics, Inc. (C4T) is a clinical-stage biopharmaceutical company focused on advancing targeted protein degradation science [4] - The company will participate in two investor conferences in March 2025, indicating active engagement with the investment community [1][2][3] Conference Participation - C4T management will present at the TD Cowen 45th Annual Healthcare Conference on March 3rd at 9:10 am ET in Boston, MA, with a live webcast available [2] - The company will also participate in the Leerink Partners Global Healthcare Conference on March 9th in Miami, FL [3] Company Overview - C4T is dedicated to creating a new generation of medicines through targeted protein degradation, aiming to transform patient outcomes [4] - The company utilizes its TORPEDO® platform to design and optimize small-molecule medicines for difficult-to-treat diseases [4] - C4T's degrader medicines aim to leverage the body's natural protein recycling system to degrade disease-causing proteins, potentially overcoming drug resistance and addressing undruggable targets [4]